Լիտվա -
լիտվերեն -
Adama
poleposition® ir mirador® mišinys
adama - koncentruota emulsija/koncentruota suspensija - azoksistrobinas + protiokonazolas - fungicidai
Եվրոպական Միություն -
լիտվերեն -
EMA (European Medicines Agency)
sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 ir 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 ir 5.
Եվրոպական Միություն -
լիտվերեն -
EMA (European Medicines Agency)
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
Եվրոպական Միություն -
լիտվերեն -
EMA (European Medicines Agency)
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
Եվրոպական Միություն -
լիտվերեն -
EMA (European Medicines Agency)
kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
Լիտվա -
լիտվերեն -
SMCA (Valstybinė vaistų kontrolės tarnyba)
azacitidine icg farma
icg farma, uab - azacitidinas - milteliai injekcinei suspensijai - 25 mg/ml - azacitidine
Լիտվա -
լիտվերեն -
SMCA (Valstybinė vaistų kontrolės tarnyba)
iohexol icg farma
icg farma, uab - joheksolis - injekcinis tirpalas - 647 mg/ml - iohexol
Լիտվա -
լիտվերեն -
SMCA (Valstybinė vaistų kontrolės tarnyba)
iohexol icg farma
icg farma, uab - joheksolis - injekcinis tirpalas - 755 mg/ml - iohexol